$2.78
00.00%
Pre-Market: Jul 19, 4:02 PM EDT
15 minutes delayed
Comments
Loading...
Trevi Therapeutics
TRVINASDAQ
Trevi Therapeutics (NASDAQ:TRVI) Stock, Earnings Estimates, EPS, And Revenue
Trevi Therapeutics reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Earnings Date
Aug 8
EPS Estimate
$-0.110
Quarterly Revenue Estimate
–
Annual Revenue
(as of Mar 31)
(as of Mar 31)
–
Analyze the earnings history of Trevi Therapeutics using advanced sorting and filters.
| Get Alert | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| TRVI | Trevi Therapeutics | -$0.07 | -$0.11 | — | — | $0.00 | — | — | — | 08/08/2024 | Get Alert |
| TRVI | Trevi Therapeutics | -$0.06 | -$0.10 | -$0.11 | -10.00% | $0.00 | — | $0.00 | — | 05/07/2024 | Get Alert |
| TRVI | Trevi Therapeutics | -$0.06 | -$0.09 | -$0.08 | 11.11% | $0.00 | — | $0.00 | — | 03/20/2024 | Get Alert |
| TRVI | Trevi Therapeutics | -$0.12 | -$0.09 | -$0.08 | 11.11% | $0.00 | — | $0.00 | — | 11/09/2023 | Get Alert |
| TRVI | Trevi Therapeutics | -$0.14 | -$0.08 | -$0.07 | 12.50% | $0.00 | — | $0.00 | — | 08/10/2023 | Get Alert |
| TRVI | Trevi Therapeutics | -$0.24 | -$0.07 | -$0.06 | 14.29% | $0.00 | — | $0.00 | — | 05/11/2023 | Get Alert |
| TRVI | Trevi Therapeutics | -$0.28 | -$0.10 | -$0.06 | 40.00% | $0.00 | — | $0.00 | — | 03/16/2023 | Get Alert |
| TRVI | Trevi Therapeutics | -$0.34 | -$0.13 | -$0.12 | 7.69% | $0.00 | — | $0.00 | — | 11/10/2022 | Get Alert |
| TRVI | Trevi Therapeutics | -$0.49 | -$0.17 | -$0.14 | 17.65% | $0.00 | — | $0.00 | — | 08/11/2022 | Get Alert |
| TRVI | Trevi Therapeutics | -$0.43 | -$0.29 | -$0.24 | 17.24% | $0.00 | — | $0.00 | — | 05/12/2022 | Get Alert |
| TRVI | Trevi Therapeutics | -$0.52 | -$0.30 | -$0.28 | 6.67% | $0.00 | — | $0.00 | — | 03/17/2022 | Get Alert |
| TRVI | Trevi Therapeutics | -$0.40 | -$0.40 | -$0.34 | 15.00% | $0.00 | — | $0.00 | — | 11/10/2021 | Get Alert |
| TRVI | Trevi Therapeutics | -$0.41 | -$0.48 | -$0.47 | 2.08% | $0.00 | — | $0.00 | — | 08/12/2021 | Get Alert |
| TRVI | Trevi Therapeutics | -$0.48 | -$0.52 | -$0.43 | 17.31% | $0.00 | — | $0.00 | — | 05/13/2021 | Get Alert |
| TRVI | Trevi Therapeutics | -$0.37 | -$0.44 | -$0.52 | -18.18% | $0.00 | — | $0.00 | — | 03/25/2021 | Get Alert |
| TRVI | Trevi Therapeutics | -$0.19 | — | -$0.40 | — | $0.00 | — | $0.00 | — | 11/11/2020 | Get Alert |
| TRVI | Trevi Therapeutics | -$0.63 | — | -$0.41 | — | $0.00 | — | $0.00 | — | 08/13/2020 | Get Alert |
| TRVI | Trevi Therapeutics | -$0.27 | — | -$0.48 | — | $0.00 | — | $0.00 | — | 05/07/2020 | Get Alert |
| TRVI | Trevi Therapeutics | — | — | -$0.37 | — | — | — | $0.00 | — | 03/16/2020 | Get Alert |
| TRVI | Trevi Therapeutics | — | — | -$0.19 | — | — | — | $0.00 | — | 11/14/2019 | Get Alert |
| TRVI | Trevi Therapeutics | — | — | -$0.63 | — | — | — | $0.00 | — | 08/12/2019 | Get Alert |
Trevi Therapeutics (TRVI) Earnings Per Share
Quarterly Earnings Surprise Amount
| Fiscal Quarter End | Date Reported | Actual EPS | Estimated EPS | Surprise % |
|---|---|---|---|---|
| Mar 2024 | 2024-05-07 | $-0.11 | $-0.10 | -10.0 % |
| Dec 2023 | 2024-03-20 | $-0.08 | $-0.09 | 11.1 % |
| Sep 2023 | 2023-11-09 | $-0.08 | $-0.09 | 11.1 % |
| Jun 2023 | 2023-08-10 | $-0.07 | $-0.08 | 12.5 % |
Trevi Therapeutics (TRVI) Revenue
Quarterly Revenue Surprise Amount
| Fiscal Quarter End | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
|---|---|---|---|---|
FAQ
When is Trevi Therapeutics (NASDAQ:TRVI) reporting earnings?
Trevi Therapeutics (TRVI) is scheduled to report earnings on August 8, 2024. The last reported earnings were for reported on May 7, 2024 for Q1.
What were the latest earnings per share (EPS) for Trevi Therapeutics (NASDAQ:TRVI)?
The Actual EPS was $-0.11, which missed the estimate of $-0.10.
What were Trevi Therapeutics’s (NASDAQ:TRVI) revenues?
The Actual Revenue was $0K, which hit the estimate of $0K.
Browse earnings estimates, EPS, and revenue on all stocks.